Trial Parameters
Condition Diabetic Foot Ulcers
Sponsor Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Study Type OBSERVATIONAL
Phase N/A
Enrollment 600
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2022-11-01
Completion 2025-03
Interventions
HBOT
Brief Summary
Overview of available data to assess the benefits of HBOT to DFU patients
Eligibility Criteria
Inclusion Criteria: * Diabetes mellitus * Meggitt-Wagner classification grade 2-4, existing \> 4 weeks * Complete 1 year follow-up Exclusion Criteria: * Chronic Obstructive Pulmonary Disease (COPD) GOLD IV * Treatment with chemotherapy, immunosuppressive drugs or systemic corticosteroids within the last 3 months * Metastasized malignancy * Left ventricular ejection fraction (EF) \<20% or external pacemaker * Recent thoracic or middle ear surgery * Severe epilepsy * Uncontrollable high fever * Pregnancy